12 insiders reported 268 Form 4 transactions for Adaptive Biotechnologies Corp (ADPT) over the past 18 months (most recent 2026-07-07). Recent activity: ROBINS HARLAN S (Chief Scientific Officer) Sell 239,351 shares, ROBINS HARLAN S (Chief Scientific Officer) Sell 146,889 shares, LO FRANCIS (Chief People Officer) Buy 12,637 shares, BOBULSKY SUSAN (Chief Commercial Officer, MRD) Sell 487 shares, LO FRANCIS (Chief People Officer) Buy 3,300 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | ROBINS HARLAN S | Chief Scientific Officer | Sell | 239,351 | $5.2M |
| 2026-07-07 | ROBINS HARLAN S | Chief Scientific Officer | Sell | 146,889 | $3.3M |
| 2026-07-06 | LO FRANCIS | Chief People Officer | Buy | 12,637 | $106,909 |
| 2026-07-06 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | 487 | $10,714 |
| 2026-07-06 | LO FRANCIS | Chief People Officer | Buy | 3,300 | $40,062 |
| 2026-07-06 | LO FRANCIS | Chief People Officer | Buy | 12,206 | $103,263 |
| 2026-07-06 | LO FRANCIS | Chief People Officer | Buy | 4,688 | $18,705 |
| 2026-07-06 | LO FRANCIS | Chief People Officer | Buy | 14,064 | $114,200 |
| 2026-07-06 | LO FRANCIS | Chief People Officer | Sell | 8,743 | $193,920 |
| 2026-07-06 | LO FRANCIS | Chief People Officer | Sell | 42,261 | $950,872 |
| 2026-07-06 | LO FRANCIS | Chief People Officer | Buy | 12,626 | $98,483 |
| 2026-07-06 | LO FRANCIS | Chief People Officer | Buy | 12,600 | $152,964 |
| 2026-07-06 | LO FRANCIS | Chief People Officer | Buy | 3,500 | $27,300 |
| 2026-07-06 | LO FRANCIS | Chief People Officer | Sell | 44,838 | $1.0M |
| 2026-06-30 | BENZENO SHARON | Chief Commercial Ofc Imm Med | Buy | 11,034 | $133,953 |
| 2026-06-30 | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sell | 11,034 | $231,714 |
| 2026-06-30 | BENZENO SHARON | Chief Commercial Ofc Imm Med | Buy | 1,837 | $22,301 |
| 2026-06-30 | BENZENO SHARON | Chief Commercial Ofc Imm Med | Buy | 24,944 | $211,026 |
| 2026-06-30 | BENZENO SHARON | Chief Commercial Ofc Imm Med | Buy | 24,944 | $99,527 |
| 2026-06-30 | BENZENO SHARON | Chief Commercial Ofc Imm Med | Buy | 51,570 | $418,748 |
| 2026-06-30 | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sell | 154,768 | $3.3M |
| 2026-06-17 | ROBINS HARLAN S | Chief Scientific Officer | Sell | 100,000 | $1.7M |
| 2026-06-17 | ROBINS HARLAN S | Chief Scientific Officer | Sell | 6,160 | $110,942 |
| 2026-06-08 | LO FRANCIS | Chief People Officer | Buy | 5,792 | $70,315 |
| 2026-06-08 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | 11,000 | $198,000 |
Source: SEC Form 4 filings · as of 2026-07-07